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 Abstract
Introdouction:
Periodontal treatment could have a positive 
effect on diabetes control . In this study, the 
researchers evaluated the efficacy of utilizing 
glucometer devices to detect glycemic levels in 
dental offices on inducing motivation towards 
the oral health care of diabetic patients. 
Materials and methods: Eighty volunteer pa-
tients with moderate periodontitis were select-
ed for participation in one of the two groups (40 
diabetic patients and 40 non-diabetics); the two 
groups were unified based on age and sex. Each 
participant’s baseline blood glucose level with 2 
hours post-prandial test (2 hpp) and periodontal 
parameters of CAL, PI, and BI were measured, 
and the two groups underwent non-surgical 
periodontal treatment accompanied by com-
prehensive oral hygiene instructions. Then, 2 
hpp was measured using a glucometer after 1 
week and 1 month. All periodontal parameters 
were evaluated again 1 month after non-surgical 
treatment.
Results: The pattern of changes in 2 hpp mean 
values over time was not similar for the two 
groups. In the diabetic patients, the mean of 2 
hpp values after 1 week (T1) and 1 month (T2) 
significantly decreased when compared with 
that at baseline (T0) (both p < 0.001). Moreover, 
the mean of 2 hpp values at T2 was significantly 
lower than that of T1 (p < 0.001). All periodontal 
parameters significantly decreased at T2 com-
pared to T0 in both groups, but the difference 
between two time points was significantly higher 
only for CAL in the diabetic group compared to 
the non-diabetic group (p = 0.022).
Conclusion:The use of a glucometer, as a 
proactive behavior to increase motivation, was 
not as effective as oral hygiene instructions on 
plaque control improvement in diabetic patients 
with chronic periodontitis. 
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alence and severity of diabetes-related complica-
tions, including retinopathy, diabetic neuropathy, 
proteinuria, cardiovascular complications, and 
delayed wound healing.(1) In previous studies, 
many intervention trials and randomized control 
trials (RCTs) have been conducted on the effect 
of periodontal treatment on the improvement of 
glycemic control in diabetic patients.(11, 12) Most 
findings have confirmed the positive influence 
of periodontal treatment on glycemic control. 
However, a study conducted by Auyeung et al., 
with one year of follow-up, obtained different 
results.(13) Furthermore, several meta-analyses(14, 
15) on this subject confirmed that the treatment of 
periodontal disease in diabetic patients (at least 
in the short term) causes an average 0.4% reduc-
tion in their HbA1c levels. This value is equiv-
alent to the effect of adding a second drug to a 
diabetes patient’s pharmaceutical regimen and 
is clinically effective in reducing diabetic com-
plications.(1) A study conducted in 2010 stated(16) 
that diabetic patients’ awareness of diabetes and 
its relationship to periodontal health is low and 
that most patients were not well-informed of the 
oral health complications of their disease and the 
requirements for proper preventive care. Hence, 
healthcare providers have recently focused on 
education and self-monitoring, through lifestyle 
and oral health programs, to manage diabetes and 
periodontitis in the long term.(1, 17, 18) The logic be-
hind oral health programs involves the impact of 
plaque control on eradicating inflammation, the 
initiator of a vicious circle of destructive perio-
dontitis and diabetes.(1) A study done by Kneckt 
et al. has demonstrated that diabetic patients who 
have been successful in managing their gingivi-
tis have experienced better glycemic control and 
lower mean HbA1c levels.(19) The present study 
aimed to find a way to motivate diabetic patients 
about plaque control. That is to say, we hypoth-
esized that, if non-surgical periodontal treatment 
causes improvement in glycemic control among 
diabetic patients, then using a method in the clin-
ic to compare their glycemic levels 1 week and 
1 month after sub-gingival scaling would enable 
patients to objectively understand how periodon-
tal care can help them control their diabetes and, 
hence, motivate them to pay more attention to 
plaque control. 
This is crucial, because diabetic patients regard 
diabetes as a life-threatening disease, which is 
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 Introduction
Diabetes mellitus (DM) is a chronic disease that 
is characterized by impaired glucose metabo-
lism. Diabetes and its complications have been a 
major public health problem for many years. (1, 2) 
The prevalence of diabetes, according to WHO, 
was approximately 10% in 2008 and is estimated 
to double by 2030. (2) There are different types of 
diabetes: type 1, type 2, and gestational diabetes. 
Among these, type 2 diabetes, called non-insulin 
dependent or adult onset diabetes, is known to be 
the most common type (>80%).(3)
Diabetic patients are known to be susceptible 
to developing periodontitis. Periodontitis is a 
chronic inflammatory disease that is a response 
to the presence of subgingival biofilm; it leads to 
the destruction of supporting periodontal struc-
tures and eventually to tooth loss. (4) Chronic 
periodontitis is associated with elevated levels 
of various systemic markers of inflammation, 
such as C-reactive protein (CRP) and interleukin 
6 (IL-6).(3) Periodontitis treatment modulates the 
related excessive systemic and local inflamma-
tory events.
Chronic hyperglycemia, through the excessive 
accumulation of advanced glycation end prod-
ucts (AGEs), impairs vascular integrity and the 
normal synthesis, maturation, and maintenance 
of collagen.(5) It also inhibits the proliferation 
and differentiation of PDL cells (6) and impedes 
cellular migration and repair.(7) On the other 
hand, diabetes is associated with elevated levels 
of systemic markers of inflammation.(8) For ex-
ample, while studying diabetes type II, scholars 
noticed that both hemoglobin A1c (HbA1c)>8% 
and random glucose levels were associated with 
higher levels of interleukin 1 beta (IL-1β) in gin-
gival crevicular fluid (GCF).(9) In addition, in 
diabetes type I, the levels of prostaglandin E2 
(PGE2) and IL-1β in GCF were elevated in both 
gingivitis and periodontitis.(10)
Recently there has been an emphasis on a two-
way relationship between diabetes and periodon-
titis.(1, 4) Not only is diabetes considered a major 
risk factor for periodontitis, diabetic patients, 
compared to non-diabetics (depending on the 
level of their glycemic control), are 2 to 3 times 
more susceptible to developing periodontitis. 
Moreover, periodontal infection could negatively 
influence glycemic control and increase the prev-
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 Materials and Methods
lowing measurements were performed: first, the 
plaque index (PI) (O’Leary) was measured. It is 
worth mentioning that, before the measurement, 
the patient’s mouth was washed with water tape 
and then the patient chewed a disclosing tablet 
for at least 1 min. Thereafter, the bleeding index 
(BI) (i.e., the Silness-Löe index) was prepared: 
a periodontal probe was introduced into the in-
terproximal areas and, after 15 to 30 s, bleeding 
was recorded when it was present. Then, using 
a William’s probe, probing depth, mucogingival 
junction, and recession were measured on the 
following sites: 3 points buccally (mesio-buccal, 
middle root, and disto-buccal) and 3 points lin-
gually (mesio-lingual, middle root, and disto-lin-
gual) around all of the patient’s teeth. The clin-
ical attachment level (CAL) was calculated by 
adding recession to the probing depth measure-
ments. Oral hygiene was instructed using a soft 
toothbrush (Oral B sensitive toothbrush) and a 
modified Bass technique on both the study mod-
el and the patient’s mouth and was checked sev-
eral times using the same toothpaste (Parodon-
tax) and dental floss. Since the measured indices 
of the study were all quantitative, the intraclass 
correlation coefficient (rICC) was used to evalu-
ate agreement. The rICC value for all parameters 
were greater than 0.85, showing an acceptable 
level of agreement. All measurements were done 
by one dentist in separate chartings at baseline 
and 1 month after non-surgical treatment. Then, 
they were checked by an experienced periodon-
tist. 
During the study, all patients were advised to eat 
breakfast, including only a palm-sized piece of 
bread and a piece of white cheese about the size 
of a cube (15 gr). At least 2 h after having break-
fast, the patients’ blood glucose was tested with 
a glucometer (Easygluco Auto Coding™) in the 
dental office and documented. The periodontal 
therapy procedures were started with supragin-
gival and subgingival scaling and root planing 
using cavitron (Joya) and Bracy curettes (Hu-
Friedy) within 2 to 4 sessions, depending on the 
amount of the calculus and patient cooperation. 
One week later, again approximately 2 h after 
having breakfast, each patient’s blood glucose 
was tested with a glucometer. One month later, 
during a recall session, all the above measure-
ments and tests were performed and documented
more worthwhile to care about than periodonti-
tis. Therefore, we used a glucometer as an easy, 
economic, and accessible device to record glu-
cose levels in the dental office. 
The present study was designed as a prospective 
parallel study that compared groups of diabetics 
and healthy controls. All patients gave informed 
consent.
Due to the lack of an appropriate article compar-
ing levels of 2-h post-prandial glucose (2 hpp) 
by using a glucometer after non-surgical perio-
dontal treatment, the sample size was calculated 
based on the effect of intervention (non-surgical 
therapy) on diabetic patients.(11) In this respect, 
the sample size needed, based on a comparison 
of the mean value of CAL in diabetic patients 
before (3.14 ± 1.08) and after (2.8 ± 1.09) inter-
vention at α = 0.05 and power = 80%, was deter-
mined to be 18; however, to increase reliability 
and comparability with the control group, the 
required sample size in both the case and control 
groups was set at 40 subjects.
80 volunteer patients (diabetic and non-diabet-
ics) were selected from patients referred to the 
periodontal department from different dental 
centers. The inclusion criteria were as follows:
In the case group, subjects diagnosed with dia-
betes mellitus type 2 were treated with an oral 
agent (metformin) according to the patient’s 
medical history, aged over 18 years old, no anti-
biotic treatment during last 3 months, more than 
30% of teeth affected by chronic periodontitis, 
no history of periodontal treatment, and the pres-
ence of at least 20 teeth. In the control group, no 
history or signs of diabetes were present in either 
the patients or their families; otherwise, all other 
criteria were the same as the case group. Subjects 
were cooperative and signed the consent forms.
The participants, all of whom were referred 
from different dental centers, were divided into 
two groups as follows: a diabetic group of 40 
patients (under oral hypoglycemic agent thera-
py) who, based on the default glucometer level 
(Easygluco Auto Coding™, Infopia Co., Korea), 
had a 2 hpp glycemic level > 140 and a control 
group of 40 non-diabetic patients. Before the 
beginning of the study, each participant’s age, 
weight, and height were documented to record 
his or her body mass index (BMI). Then, the fol-
- 4 -
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once again. Finally, the differences between 
blood glucose level, plaque, and bleeding index 
and the mean attachment level were measured.
Statistical Analysis:
Student’s t-test was used to evaluate the contin-
uous variables, such as height, weight, and age, 
and the differences between the mean attach-
ment level, plaque, and bleeding indices found 
in the two groups. The chi-squared test was used 
to compare sex ratio and gender-based differenc-
es between the two groups. Blood glucose lev-
els at different times were analyzed by repeated 
measures ANOVA. In this analysis, time of eval-
uation was considered the within-subject effect 
and the study groups the between-subject effect. 
Normality of variable distribution was evaluated 
with a Kolmogorov-Smirnov test. The signifi-
cant level was set at 0.05. The statistical analysis 
was performed using SPSS 16 software.
 Results
In this study, 80 patients (40 diabetic and 40 
non-diabetic patients) were evaluated. There 
were no significant differences in the baseline 
characteristics between the two groups. In the 
diabetic group,
there were 22 females and 18 males, while the 
control group consisted of 18 females and 22 
males (p = 0.371). The mean age in the diabetic 
and the non-diabetic group was 
44.98 ± 15.04 and 39.5 ± 14.98 (p = 0.107), re-
spectively, and the mean BMI value was 26.73 
± 3.7 and 27.52 ± 5.24 (p = 0.437), respectively.
The blood glucose levels of all patients were 
evaluated before scaling and root planing, as 
well as 1 week and 1 month after the procedure 
was performed (Table 1).
There was a significant interaction effect be-
tween group and time (p < 0.001);
that is, the pattern of changes in 2 hpp mean val-
ue over time points was not similar for the two 
groups. More specifically, for DM patients, the 
mean of their 2 hpp values at T1 (193.60 ± 45.95) 
and T2 (186.40 ± 44.02) significantly decreased 
when compared with that at T0 (216.15 ± 56.58) 
(both p < 0.001). Moreover, the mean of DM pa-
tients’ 2 hpp values at T2 was also significantly 
lower than that at T1 (p < 0.001). However, there 
was no significant difference between the means 
of the control group’s 2 hpp values at any of the 
three time points (all were p > 0.05).
The mean clinical attachment level (CAL), 
plaque, and bleeding indices (PI, BI) were as-
sessed in the two groups before and 1 month after 
scaling and root planing (Table 2).
As shown in Table 2, the means of CAL, BI, and 
PI decreased 1 month after scaling and root plan-
ing, exhibiting statistically significant differences 
between those parameters before and after scal-
ing and root planing in both groups (p < 0.05).
Whereas the mean and standard deviation of 
differences in the mean CAL from T0 to T2 in 
diabetic patients was −0.576 ± 0.406, in non-di-
abetic patients, they were −0.364 ± 0.411, and 
these differences were statistically significant 
betweenthe two groups (p = 0.022). 
The difference in BI from T0 to T2 in diabetic pa-
tients was −0.116 ± 0.199 and −0.097 ± 0.0249 in 
non-diabetic subjects; these differences were sta-
tistically not significant between the two groups 
(p = 0.542). Also, the mean and standard devi-
ation of differences in PI at T0 to T2 in the two 
groups was as follows: −0.09 ± 0.05 in the dia-
betic group and −0.078 ± 0.059 in the non-dia-
betic group. However, these differences were not 
statistically significant (p =0.321).




Before (T0) 1 week (T1) 1 month (T2)
Blood Glucose 
(diabetic)
216.15 ± 56.58ª 193.60 ± 45.95ˢ 186.40 ± 44.02ˣ <0.001 
Blood Glucose 
(non-diabetic)
83.38 ± 13.67ª 78.30 ± 12.90ª 80.38 ± 11.01ª 0.134
In each group, mean 2 hpp values with the same lowercase letters were not statistically different.
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Group Before (T0) After(T2) Difference
CAL
1 2.97 ± 0.63 2.39 ± 0.77 −0.576 ± 0.406 <0.001
2 2.86 ± 0.88 2.50 ± 0.92 −0.364 ± 0.411 <0.001
P-value 0.522 0.022
BI
1 0.7315 ± 0.1379 0.6153 ± 0.1472 −0.1163 ± 0.1988 <0.001
2 0.649 ± 0.164 0.5521 ± 0.1765 −0.0969 ± 0.0249 0.019
P-value 0.017 0.542
PI
1 0.6819 ± 0.1324 0.5919 ± 0.1275 −0.0904 ± 0.0502 <0.001
2 0.6887 ± 0.1716 0.6105 ± 0.1819 −0.0782 ± 0.0587 <0.001
P-value 0.843 0.321
Table 2. Distribution of mean clinical attachment level, bleeding index, and plaque index in diabetic (group 1) and non-diabetic (group 2) before and after scaling and root planing
Although, in the present study, the importance of 
periodontal treatment in decreasing diabetic pa-
tients’ blood glucose level was emphasized to the 
diabetic patients in the dental office, this failed to 
motivate them to better manage plaque control. 
Both groups, diabetic and non-diabetic, showed 
similarly positive reactions after receiving mere 
education at baseline. It is worth mentioning that 
since this study, to the best knowledge of the re-
searchers, is the first one to be conducted on the 
effect of informing and showing diabetic patients 
the importance of periodontal care on controlling 
blood glucose level, it suffers some limitations. 
Previous studies that aimed to improve oral hy-
giene in diabetic patients were planned accord-
ing to the guidelines of different education pro-
grams and a glucometer has been used by only a 
few dentists exclusively for diabetes screening. 
For example, in two studies on the management 
of diabetic patients by dentists, Forbes et al Kun-
zel et al. (20) and Forbes et al.(21) concluded that, 
although dentists found it useful to give informa-
tion to diabetic patients about the effect of oral 
hygiene on controlling diabetes, most of them 
merely participated in the discussion phase with 
patients and never exhibited a tendency to take 
proactive measures, such as using a finger-stick 
(glucometer) to measure blood glucose levels 
in their dental offices. Periodontists exhibit-
ed a greater tendency to involve themselves in 
proactive behaviors, but general dentists rarely 
assumed responsibility in this regard.(22) There-
fore, the researchers declare that, as the number 
of patients with diabetes increases, so does the 
responsibility of dentists to play an active role in 
helping their patients manage diabetes.
Saengtipbovorn et al.(23), in their study, published 
in 2015, proposed a program in which lifestyle 
change and dental care, with 6 months of fol-
low-up, could improve oral and systemic health 
in diabetic patients. The dental care program 
consisted of group and individual education on 
DM complications and their relationship to oral 
health, plus using a toothbrush, dental floss, and 
interproximal brush. Furthermore, monthly ed-
ucational booster programs were performed. 
The success of this 6-month program in improv-
ing periodontal (BI, CAL, bleeding on probing 
(BOP)) and diabetic status (HbA1c and fasting 
plasma glucose (FPG)) seemed to the result of 
engaging dentists with individual patients and 
having educational booster sessions.
In the present study, the follow-up period was 1 
month because the CALs were in the range of 
2–3 mm and Morrison and Lowenguth demon-
strated that, after 1 month of non-surgical per-
iodontal treatment, the inflammation caused by 
periodontitis would ameliorate.(24) Furthermore, 
the effect of non-surgical treatment on the de-
cline of glycemic levels in diabetics is associated 
with the reduction of local and systemic inflam-
mation related to periodontal infection.(1-3) How-
ever, it seems that improvement in the glycemic 
levels of patients, as measured with a glucometer 
in a dental office, is advantageous in motivating 
diabetics to improve their periodontal care only 
while treating periodontal disease and resolving 
inflammation. 
On the one hand, the present research investigat-
ed the influence of demonstrating the use of a 
- 6 -
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patient is taking vasopressor drugs, and chang-
es in microcirculation. In addition, glucometers 
fail to be accurate when glucose values approach 
the endpoints of hypoglycemia and hyperglyce-
mia. However, in euglycemia, the measurements 
are close to the real values. In the present study, 
glucometer measurements were utilized just to 
compare glucose levels at baseline, 1 week, and 
1 month after periodontal treatment, not to make 
serious clinical decisions for diabetes; there-
fore, the application of glucometers in this study 
seems to be acceptable.
In contrast to most of the previous studies, which 
used markers, such as fasting blood sugar (FBS) 
and HbA1c, to evaluate the level of glycemic 
control, we used 2 hpp. HbA1c is a reliable 
marker for detecting long-term diabetes control 
(during the last 3 months), while 2 hpp is an ap-
propriate marker for evaluating the level of dia-
betes control in short-term intervals and, hence, 
is suitable to be used in a dental office. 2 hpp is 
also more helpful in giving information about di-
abetic complications, especially macro-vascular 
complications, than other markers, such as FBS.
(27)
Based on the literature, the risk of periodontal 
disease in diabetic patients is influenced by de-
mographic characteristics, glycol-hemoglobin 
level, and BMI (31), while the clinical response to 
non-surgical periodontal therapy is influenced by 
baseline disease severity and BMI.(32)Therefore, 
to exclude confounding factors in this study, the 
case and control groups were matched based on 
age, sex, disease severity, and BMI.
Among the periodontal parameters (BOP, PI, 
CAL), checked in the present study, only CAL 
appeared to improve statistically significantly 
after non-surgical treatment in diabetic patients 
compared to non-diabetics. This probably could 
not be explained by improved gingival health in 
diabetes patients, since well-controlled diabetic 
patients might respond to non-surgical treatment 
the same as healthy individuals, but uncontrolled 
diabetes might interfere with the normal healing 
process.(6) Instead, it is likely that this result is 
associated with the higher inflammatory status of 
diabetic patients with periodontitis, which leads 
to technical errors while measuring CAL with 
a periodontal probe, as well as more significant 
differences in periodontal tissue after subgingi-
val debridement and resolving the underlying 
glucometer in the dental office on the improve-
ment of diabetic patients’ plaque index. Howev-
er, obtaining an optimal plaque index score ap-
pears to be dependent upon developing patients’ 
dexterity at proper plaque removal. Thus, we 
should not overlook that this method could have 
a positive influence on diabetic patients when the 
dental practitioner engages him/herself in their 
disease management and that the use of a glu-
cometer could be an easy and useful method to 
provide an overview of patients’ glucose levels, 
thus enabling patients and dentists to confirm the 
positive effect of periodontal treatment on diabe-
tes. Hence, in future studies, it might be worth-
while to consider the influence of this method 
on increasing diabetic patients’ participation in 
long-term periodontal care follow-ups. On the 
other hand, this method seems to suffer some 
shortcomings, the first one being the short dura-
tion of its effects. 
A review based on meta-analysis has reported 
that the effect of periodontal treatment on glyce-
mic level reduction can be documented in a short 
time (3 months) (25, 26); therefore, if it is to be used 
merely as an aid for providing objective under-
standing to diabetic patients, it should be accom-
panied by proper education about the chronic 
features of periodontal disease that needs long-
term maintenance.
Another point in the present study is using a glu-
cometer as an easy-to-access device to measure 
chairside 2 hpp glycemic level in the dental of-
fice. As mentioned previously, finger-sticks have 
been used in the dental office in previous studies 
(20) as a device for diabetes screening, but most 
dentists were unwilling to use such devices to 
monitor glucose levels. Thus, it is crucial to in-
form dentists about the beneficial effects of glu-
cometers. 
Glucometers are accepted among diabetic pa-
tients as s self-monitoring devices for information 
about changes in glycemic level at short inter-
vals. Moreover, they are accepted to be valuable 
in the primary health care setting in controlling 
diabetes.(27, 28) A study has been conducted on 
the accuracy of glucometer measurements.(29) A 
study carried out by Robel et al.(30) maintains that 
the accuracy of glucometers depends upon many 
factors, such as the proper use of the devices, 
sample source, and patient parameters, includ-
ing pH, blood oxygen, hematocrit, whether the 
- 7 -
tients’ glucose level so that patients and dentists 
can confirm the positive impact of periodontal 
treatment on diabetes. However, in comparison 
to proper oral hygiene instruction, no additional 
benefits were derived from this method in terms 
of improving diabetic patients’ plaque index. 
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inflammation.Based on this study, since internal 
medicine specialists are often the first members 
of a medical team to encounter diabetic patients, 
they are recommended to educate their patients 
on the importance of oral health, along with reg-
ular follow-ups in their office; they are expected 
to refer every diabetic patient to a dentist as well. 
Dental practitioners should also participate in an 
oral health education program that emphasizes 
lifestyle changes in diabetic patients.
 Conclusion
Non-surgical periodontal treatment is effective 
in improving glycemic levels in diabetic pa-
tients; in addition, using a glucometer is an easy 
and useful method to obtain an overview of pa-
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